倾向性评分匹配分析提示肾移植前无症状冠心病筛查不能预测心脏事件
该研究基于2011-2017年英国肾移植受者前瞻性队列,评估移植前无症状冠心病筛查(负荷试验或冠状动脉造影)与移植后5年内主要不良心脏事件(MACE)的关联。经倾向性评分匹配后纳入1760例(筛查组与未筛查组各880例),结果显示筛查与90天、1年及5年MACE均无显著关联,而年龄、男性及缺血性心脏病史与MACE相关。
要点
- 肾移植前无症状冠心病筛查与移植后5年内MACE无显著关联。
- 匹配后筛查组与未筛查组90天、1年、5年MACE风险比均无统计学意义。
- 年龄、男性性别和缺血性心脏病史与MACE发生相关。
核心结论
- 肾移植前无症状冠心病筛查与移植后5年内MACE无显著关联,不应进行无选择筛查。
研究设计与样本
- 基于英国Access to Transplant and Transplant Outcome Measures前瞻性队列,纳入2011-2017年18个中心2572例肾移植受者,进行倾向性评分匹配分析。
主要发现
- 总体90天、1年和5年MACE发生率分别为0.9%、2.1%和9.4%。
- 匹配后筛查与MACE在90天(HR 0.80,95%CI 0.31-2.05)、1年(HR 1.12,95%CI 0.51-2.47)和5年(HR 1.31,95%CI 0.86-1.99)均无显著关联。
- 年龄、男性性别和缺血性心脏病史与MACE相关。
关键数值与推荐
- 筛查组与未筛查组各880例,筛查比例在各中心间为5%-100%。
临床怎么用
- 应重新评估对肾移植受者进行无选择无症状冠心病筛查的实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Screening for asymptomatic coronary artery disease prior to kidney transplantation aims to reduce peri- and post-operative cardiac events. It is uncertain if this is achieved. Here, we investigated whether pre-transplant screening with a stress test or coronary angiogram associated with any difference in major adverse cardiac events (MACE) up to five years post-transplantation. We examined a national prospective cohort recruited to the Access to Transplant and Transplant Outcome Measures study who received a kidney transplant between 2011-2017, and linked patient demographics and details of cardiac screening investigations to outcome data extracted from the Hospital Episode Statistics dataset and United Kingdom Renal Registry. Propensity score matched groups were analyzed using Kaplan-Meier and Cox survival analyses. Overall, 2572 individuals were transplanted in 18 centers; 51% underwent screening and the proportion undergoing screening by center ranged from 5-100%. The incidence of MACE at 90 days, one and five years was 0.9%, 2.1% and 9.4% respectively. After propensity score matching based on the presence or absence of screening, 1760 individuals were examined (880 each in screened and unscreened groups). There was no statistically significant association between screening and MACE at 90 days (hazard ratio 0.80, 95% Confidence Interval 0.31-2.05), one year (1.12, 0.51-2.47) or five years (1.31, 0.86-1.99). Age, male sex and history of ischemic heart disease were associated with MACE. Thus, there is no association between screening for asymptomatic coronary artery disease and MACE up to five years post-transplant. Practices involving unselected screening of transplant recipients should be reviewed.
引用
- Nimmo A, Forsyth JL, Oniscu GC, et al. A propensity score-matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients. Kidney Int. 2020. PMID: 33171171. doi:10.1016/j.kint.2020.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。